Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity

Journal of Rheumatology

Volumn 23, Issue 8, 1996, Pages 1375-1379

  Boffa, Marie Claire ^a   Berard, Madeleine ^b   Sugi, Toshitaka ^b   McIntyre, John A ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

Cofactors; Factor XI; Phospholipid binding proteins; Prekallikrein; Vascular cutaneous disesases

Indexed keywords

PHOSPHATIDYLETHANOLAMINE ANTIBODY; PHOSPHOLIPID ANTIBODY; PREKALLIKREIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVEDO RETICULARIS; MALE; PRIORITY JOURNAL; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN ISOTYPES; KININOGENS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHOSPHATIDYLETHANOLAMINES; SKIN DISEASES, VASCULAR; THROMBOSIS;

EID: 0029738202     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: ß2-glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sc USA 1990;87:4120-4.
2. Galli M, Comfurius P, Maassen C, et al: Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-7.
3. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA: Lupus anticoagulant IgG's are not directed to phospholipids only but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991;66:629-32.
4. Wagenknecht DR, McIntyre JA: Changes in ß2-glycoprotein I antigenicity induced by phospholipid binding. Thromb Haemost 1993;69:361-5.
5. Matsuura E, Igarashi Y, Yasuda T, Koike T, Triplett DA: Anticardiolipin antibodies recognized ß2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62.
6. Wu JR, Lentz BR: Phospholipid-specific conformational changes in human prothrombin upon binding to procoagulant acidic lipid membranes. Thromb Haemost 1994;5:596-604.
7. Roubey RAS: Autoantibodies to phospholipid-binding proteins: A new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 1994;84:2854-67.
8. Galli M, Barbui T, Zwaal RFA, Comfurius P, Bevers EM: "Antiphospholipid antibodies": Involvement of protein cofactors. Haematologica 1993;18:1-4.
9. Wurm H: Beta 2 glycoprotein 1 (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 1984;16:511-5.
10. Schousboe I: B2-glycoprotein I: A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985;66:1086-91.
11. Nimpf J, Bevers EM, Bomans PHH, et al. Prothrombinase activity of human platelets is inhibited by B2-glycoprotein I. Biochim Biophys Acta 1986;884:142-9.
12. Costing JD, Dersken RHWM, Bobbink IWG, Hackeng TM, Bouma BN, De Groot PG: Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: An explanation for their pathogenic mechanisms? Blood 1993;81:2618-25.
13. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T: Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-8.
14. Cabral AR, Cabiedes J, Alarcon-Segovia D, Sanchez-Guerrero J: Phospholipid specificity and requirement of ß2-glycoprotein 1 for reactivity of antibodies from patients with primary antiphospholipid syndrome. J Autoimmun 1992;5:787-801.
15. Roubey RAS, Pratt CW, Buyon JP, Winfield JB: Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta2-glycoprotein I. J Clin Invest 1992;90:1100-4.
16. Hunt JE, McNeil HP, Morgan GJ, Crameri R, Krilis SA: A phospholipid beta 2-glycoprotein 1 complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992;1:75-81.
17. Ordi J, Selva A, Monegal F, Porce JM, Martinez Costa X, Vilardeil M: Anticardiolipin antibodies and dependence of a serum cofactor. A mechanism of thrombosis. J Rheumatol 1993;20:1321-4.
18. Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto M: Detection of 62 glycoprotein 1 dependent antiphospholipid antibodies and anti-ß2 glycoprotein 1 antibody in patients with systemic lupus erythematosus and in patients with syphilis. Int Arch Allergy Immunol 1994;103:239-44.
19. Sugi T, McIntyre JA: Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995;86:3083-9.
20. Berard M, Chantome R, Marcelli A, Boffa MC: Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases. J Rheumatol 1996;23:1369-74.
21. Jiang Y, Nawarawong W, Meloni FJ, Schmaier AH: Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets. Thromb Haemost 1992;68:143-8.
22. Matsuura E, Igarashi Y, Fujimoto M, et al: Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992;148:3885-91.
23. Boffa MC, Berard M, Karmochkine M: Heterogeneity of antiphospholipid antibodies and of their cofactors. Clin Rev Allergy 1995;13:101-6.